Rubino V, Huppi M, Hopner S, Tortola L, Schnuriger N, Legenne H
Cell Rep Med. 2024; 5(11):101826.
PMID: 39536753
PMC: 11604404.
DOI: 10.1016/j.xcrm.2024.101826.
Jung S, Nelde A, Maringer Y, Denk M, Zieschang L, Kammer C
Front Oncol. 2024; 14:1458449.
PMID: 39469638
PMC: 11513396.
DOI: 10.3389/fonc.2024.1458449.
Alsowaida D, Larsen B, Hachmer S, Azimi M, Arezza E, Brunette S
bioRxiv. 2024; .
PMID: 39386486
PMC: 11463586.
DOI: 10.1101/2024.09.24.614809.
Wu K, Li Y, Nie B, Guo C, Ma X, Li L
Int J Oncol. 2024; 65(5).
PMID: 39329212
PMC: 11436260.
DOI: 10.3892/ijo.2024.5699.
Joshi P, Keyvani Chahi A, Liu L, Moreira S, Vujovic A, Hope K
Hemasphere. 2024; 8(8):e116.
PMID: 39175825
PMC: 11339706.
DOI: 10.1002/hem3.116.
Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties.
Boutzen H, Murison A, Oriecuia A, Bansal S, Arlidge C, Wang J
Leukemia. 2024; 38(10):2090-2101.
PMID: 39169113
PMC: 11436360.
DOI: 10.1038/s41375-024-02358-9.
Glutathione overproduction mediates lymphoma initiating cells survival and has a sex-dependent effect on lymphomagenesis.
H-Alcantara A, Kourani O, Marcos-Jimenez A, Martinez-Nunez P, Herranz-Martin E, Fuentes P
Cell Death Dis. 2024; 15(7):534.
PMID: 39068166
PMC: 11283572.
DOI: 10.1038/s41419-024-06923-z.
Alkynyl nicotinamides show antileukemic activity in drug-resistant acute myeloid leukemia.
Ramdas B, Dayal N, Pandey R, Larocque E, Kanumuri R, Pasupuleti S
J Clin Invest. 2024; 134(12).
PMID: 38950330
PMC: 11178545.
DOI: 10.1172/JCI169245.
Leukemic Stem Cells and Hematological Malignancies.
Choi H, Kim B, Yoon S, Oh S, Lee D
Int J Mol Sci. 2024; 25(12).
PMID: 38928344
PMC: 11203822.
DOI: 10.3390/ijms25126639.
CD57 defines a novel cancer stem cell that drive invasion of diffuse pediatric-type high grade gliomas.
Qi L, Du Y, Huang Y, Kogiso M, Zhang H, Xiao S
Br J Cancer. 2024; 131(2):258-270.
PMID: 38834745
PMC: 11263392.
DOI: 10.1038/s41416-024-02724-5.
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.
Kaito Y, Imai Y
Int J Hematol. 2024; 120(1):34-43.
PMID: 38693419
DOI: 10.1007/s12185-024-03778-0.
Aberrant stem cell and developmental programs in pediatric leukemia.
Ling R, Cross J, Roy A
Front Cell Dev Biol. 2024; 12:1372899.
PMID: 38601080
PMC: 11004259.
DOI: 10.3389/fcell.2024.1372899.
Cytokine secretion in stem cells of cattle infected with bovine leukaemia virus.
Szczotka M, Kuzmak J
J Vet Res. 2024; 68(1):19-33.
PMID: 38525233
PMC: 10960261.
DOI: 10.2478/jvetres-2024-0012.
The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies.
Filipek-Gorzala J, Kwiecinska P, Szade A, Szade K
Front Oncol. 2024; 14:1308709.
PMID: 38440231
PMC: 10910019.
DOI: 10.3389/fonc.2024.1308709.
Metabolic regulation of chemoresistance and immuno-surveillance in AML by SHP-1.
Nat Cell Biol. 2024; 26(3):329-330.
PMID: 38396121
DOI: 10.1038/s41556-024-01350-w.
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells.
Klaihmon P, Luanpitpong S, Kang X, Issaragrisil S
Cancer Cell Int. 2023; 23(1):297.
PMID: 38012684
PMC: 10680184.
DOI: 10.1186/s12935-023-03153-9.
The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
Zhao Y, Zhang Y, Lu W, Sun R, Guo R, Cao X
BMC Med Genomics. 2023; 16(1):296.
PMID: 37980495
PMC: 10657597.
DOI: 10.1186/s12920-023-01735-0.
Sam68 is a druggable vulnerability point in cancer stem cells.
Mendes da Silva A, Yevdokimova V, Benoit Y
Cancer Metastasis Rev. 2023; 43(1):441-456.
PMID: 37792222
PMC: 11016129.
DOI: 10.1007/s10555-023-10145-8.
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li Y, Fang Y, Lyu Z, Zhu Y, Yang L
J Transl Med. 2023; 21(1):686.
PMID: 37784157
PMC: 10546755.
DOI: 10.1186/s12967-023-04575-9.
Cancers make their own luck: theories of cancer origins.
Jassim A, Rahrmann E, Simons B, Gilbertson R
Nat Rev Cancer. 2023; 23(10):710-724.
PMID: 37488363
DOI: 10.1038/s41568-023-00602-5.